These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 36167537)

  • 1. Patient-reported outcomes in a pilot clinical trial of twice-weekly hemodialysis start with adjuvant pharmacotherapy and transition to thrice-weekly hemodialysis vs conventional hemodialysis.
    Murea M; Highland BR; Yang W; Dressler E; Russell GB
    BMC Nephrol; 2022 Sep; 23(1):322. PubMed ID: 36167537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twice-Weekly Hemodialysis With Adjuvant Pharmacotherapy and Transition to Thrice-Weekly Hemodialysis: A Pilot Study.
    Murea M; Patel A; Highland BR; Yang W; Fletcher AJ; Kalantar-Zadeh K; Dressler E; Russell GB
    Am J Kidney Dis; 2022 Aug; 80(2):227-240.e1. PubMed ID: 34933066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of an individualized model of hemodialysis vs conventional hemodialysis: a study protocol for a multicenter randomized controlled trial (the TwoPlus trial).
    Murea M; Raimann JG; Divers J; Maute H; Kovach C; Abdel-Rahman EM; Awad AS; Flythe JE; Gautam SC; Niyyar VD; Roberts GV; Jefferson NM; Shahidul I; Nwaozuru U; Foley KL; Trembath EJ; Rosales ML; Fletcher AJ; Hiba SI; Huml A; Knicely DH; Hasan I; Makadia B; Gaurav R; Lea J; Conway PT; Daugirdas JT; Kotanko P;
    Trials; 2024 Jun; 25(1):424. PubMed ID: 38943204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal replacement treatment initiation with twice-weekly versus thrice-weekly haemodialysis in patients with incident dialysis-dependent kidney disease: rationale and design of the TWOPLUS pilot clinical trial.
    Murea M; Moossavi S; Fletcher AJ; Jones DN; Sheikh HI; Russell G; Kalantar-Zadeh K
    BMJ Open; 2021 May; 11(5):e047596. PubMed ID: 34031117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of outcomes between the incremental and thrice-weekly initiation of hemodialysis: a propensity-matched study of a prospective cohort in Korea.
    Park JI; Park JT; Kim YL; Kang SW; Yang CW; Kim NH; Oh YK; Lim CS; Kim YS; Lee JP;
    Nephrol Dial Transplant; 2017 Feb; 32(2):355-363. PubMed ID: 28186541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study.
    Obi Y; Streja E; Rhee CM; Ravel V; Amin AN; Cupisti A; Chen J; Mathew AT; Kovesdy CP; Mehrotra R; Kalantar-Zadeh K
    Am J Kidney Dis; 2016 Aug; 68(2):256-265. PubMed ID: 26867814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy.
    Kalantar-Zadeh K; Unruh M; Zager PG; Kovesdy CP; Bargman JM; Chen J; Sankarasubbaiyan S; Shah G; Golper T; Sherman RA; Goldfarb DS
    Am J Kidney Dis; 2014 Aug; 64(2):181-6. PubMed ID: 24840669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IHDIP: a controlled randomized trial to assess the security and effectiveness of the incremental hemodialysis in incident patients.
    Deira J; Suárez MA; López F; García-Cabrera E; Gascón A; Torregrosa E; García GE; Huertas J; de la Flor JC; Puello S; Gómez-Raja J; Grande J; Lerma JL; Corradino C; Musso C; Ramos M; Martín J; Basile C; Casino FG
    BMC Nephrol; 2019 Jan; 20(1):8. PubMed ID: 30626347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter feasibility randomized controlled trial to assess the impact of incremental versus conventional initiation of hemodialysis on residual kidney function.
    Vilar E; Kaja Kamal RM; Fotheringham J; Busby A; Berdeprado J; Kislowska E; Wellsted D; Alchi B; Burton JO; Davenport A; Farrington K
    Kidney Int; 2022 Mar; 101(3):615-625. PubMed ID: 34418414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of incremental versus conventional initiation of haemodialysis on residual kidney function: study protocol for a multicentre feasibility randomised controlled trial.
    Kaja Kamal RM; Farrington K; Wellsted D; Sridharan S; Alchi B; Burton J; Davenport A; Vilar E
    BMJ Open; 2020 Aug; 10(8):e035919. PubMed ID: 32792431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and Laboratory Changes during Incremental Transition from Twice to Thrice-Weekly Hemodialysis.
    Hur I; Wenziger C; Obi Y; Moradi H; Streja E; Tantisattamo E; Choi SJ; Lau WL; Chang Y; Jin A; Chen JLT; Kovesdy CP; Rhee CM; Kalantar-Zadeh K
    Cardiorenal Med; 2020; 10(2):97-107. PubMed ID: 31935740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Clinical Outcome Between Twice-Weekly and Thrice-Weekly Hemodialysis in Patients With Residual Kidney Function.
    Hwang HS; Hong YA; Yoon HE; Chang YK; Kim SY; Kim YO; Jin DC; Kim SH; Kim YL; Kim YS; Kang SW; Kim NH; Yang CW
    Medicine (Baltimore); 2016 Feb; 95(7):e2767. PubMed ID: 26886622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental hemodialysis in pediatric patients.
    Evgenia G; Yafa F; Hadas A; Shelly L; Amit D; Landau D; Orly H
    J Nephrol; 2023 Jul; 36(6):1571-1580. PubMed ID: 37341967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal trends in fluid management with incremental hemodialysis
.
    Bowline IG; Russell GB; Bagwell B; Crossley B; Fletcher AJ; Murea M
    Clin Nephrol; 2019 Oct; 92(4):165-173. PubMed ID: 31347496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narrative Review of Incremental Hemodialysis.
    Murea M; Moossavi S; Garneata L; Kalantar-Zadeh K
    Kidney Int Rep; 2020 Feb; 5(2):135-148. PubMed ID: 32043027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twice versus thrice weekly hemodialysis: A systematic review.
    Moorman D; Pilkey NG; Goss CJ; Holden RM; Welihinda H; Kennedy C; Halliday SM; White CA
    Hemodial Int; 2022 Oct; 26(4):461-479. PubMed ID: 36097718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic peptide levels and volume status in twice-weekly hemodialysis patients.
    Fang N; Che M; Shi L; Yu Z; Ni Z; Fang W; Pang H; Gu L; Lin X
    Ren Fail; 2021 Dec; 43(1):1259-1265. PubMed ID: 34465266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of characteristics of centers practicing incremental vs. conventional approaches to hemodialysis delivery - postdialysis recovery time and patient survival.
    Davenport A; Guirguis A; Almond M; Day C; Chilcot J; Wellsted D; Farrington K
    Hemodial Int; 2019 Jul; 23(3):288-296. PubMed ID: 30860667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional status of twice and thrice-weekly hemodialysis patients with weekly Kt/V > 3.6.
    Supasyndh O; Satirapoj B; Seenamngoen S; Yongsiri S; Choovichian P; Vanichakarn S
    J Med Assoc Thai; 2009 May; 92(5):624-31. PubMed ID: 19459522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ABCs of personalized incremental dialysis start, Le Mans style.
    Torreggiani M; Fois A; Samoreau C; Santagati G; Piccoli GB
    J Nephrol; 2022 Dec; 35(9):2417-2423. PubMed ID: 36396845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.